Please login to the form below

Not currently logged in
Email:
Password:

Bayer’s Jean-Luc Lowinski joins Sanofi as senior VP Asia

Based in Shanghai, Lowinski will oversee Sanofi’s operations in the increasingly important Asian market

Jean-Luc Lowinski - SanofiSanofi has appointed Bayer's former global head of animal health Jean-Luc Lowinski to lead its operations in the increasingly important Asian market.

Based in Shanghai as the French pharmaceutical company's senior vice president, Asia region, Lowinski previously held senior roles in a number of Asian countries, serving as head of operations in Singapore, India, Thailand, China and Japan during his time at Bayer.

Following this he was appointed head of Bayer Healthcare, China in 2003 and subsequently became head of Bayer Healthcare, Asia Pacific, and president, Bayer Yakuhin, Japan in 2007.

“I'm confident that his deep knowledge of different Asian cultures makes him ideally suited to lead our operations to continued growth and success in the region,” said Hanspeter Spek, president, global operations at Sanofi.

The pharma company recorded revenues of €2.42bn in Asia last year, up 16.6 per cent on the previous 12 months. In comparison its fortunes in the West dipped, as European sales fell 4 per cent, and its US operations recorded just single digit growth.

This year the company faces an anticipated loss in net income of €1.4bn due to increased generic competition for key products, so building on its Asian performance will be an important part of compensating for lost sales.

6th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics